Crossmark

Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients

Published Online: 2022-01-26

Published Print: 2022-12

Authors

Mlimi, Hlelolwenkosi

Naidoo, Kewreshini K.

Mabuka, Jenniffer

Ndung’u, Thumbi

Madlala, Paradise https://orcid.org/0000-0003-0641-1452
Funding

Funding for this research was provided by:

Poliomyelitis Research Foundation (18/12)

South African Research Chairs Initiative (64809)

Victor Daitz Foundation
License Information

Text and Data Mining valid from 2022-01-26

Version of Record valid from 2022-01-26
More Information

Article History

Received: 17 August 2021

Accepted: 11 January 2022

First Online: 26 January 2022

Declarations

:

: Ethical approval for the present study was obtained from the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BREC/00002085/2020). Written informed consent was obtained from all study participants at the time of recruitment and patient identity remained confidential.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current